Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures
August 30, 2023 08:30 ET
|
Aziyo Biologics
Case provides first histologic evidence that CanGaroo can catalyze development of new healthy tissue layer within an existing cardiac implantable electronic device (CIED) pocket SILVER SPRING, Md.,...
Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company
August 14, 2023 16:05 ET
|
Aziyo Biologics
Negotiating multiple LOIs to divest Orthopedic business CanGaroo® RM 510(k) resubmission to the FDA remains on track SimpliDerm® quarterly net sales up 32% year-over-year Successful transfer of...
Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
July 31, 2023 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between...
Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products
July 13, 2023 16:30 ET
|
Aziyo Biologics
SILVER SPRING, Md., July 13, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a company that develops and commercializes biologic products to improve compatibility between medical...
Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope
May 19, 2023 08:15 ET
|
Aziyo Biologics
Study Presented at Heart Rhythm Society Supports Wound-Healing Benefits in Patients Receiving Cardiac Implantable Electronic Devices SILVER SPRING, Md., May 19, 2023 (GLOBE NEWSWIRE) -- Aziyo...
Aziyo Biologics Reports Highest Sales and Gross Profit in Company History
May 10, 2023 16:05 ET
|
Aziyo Biologics
- All Four Business Segments Achieved Growth Led by Strong SimpliDerm and CanGaroo Sales - SILVER SPRING, Md., May 10, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a...
Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
May 03, 2023 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., May 03, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between...
Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo’s Cardiovascular Portfolio
April 20, 2023 16:30 ET
|
Aziyo Biologics
SILVER SPRING, Md., April 20, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between...
Aziyo Biologics Reports Record Full Year 2022 Revenues
March 22, 2023 16:01 ET
|
Aziyo Biologics
SILVER SPRING, Md., March 22, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between...
Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue Reconstruction
March 22, 2023 08:30 ET
|
Aziyo Biologics; Sientra, Inc.
SILVER SPRING, Md. and IRVINE, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve...